The BioNTech headquarters. Photo by Abdulhamid Hosbas/Anadolu Agency via Getty Images Pfizer and BioNTech announced this week that their vaccine was 90 percent effective at preventing symptomatic COVID-19 in clinical trials. The data is still preliminary and hasn’t been examined by independent researchers, but it’s ...